Alternatives for Switching from Lexapro (Escitalopram)
When switching a patient from Lexapro (escitalopram), the best alternatives include sertraline, citalopram, bupropion, mirtazapine, or venlafaxine, with the choice depending primarily on the patient's symptom profile and side effect concerns.
First-Line Alternatives to Consider
SSRIs
Sertraline (Zoloft): 50-200 mg daily
- Well-tolerated with favorable side effect profile 1
- Good option if Lexapro was partially effective but caused side effects
Citalopram (Celexa): 20-40 mg daily
- Similar mechanism to escitalopram but may have different tolerability profile
- Note FDA warning limiting maximum dose to 40 mg due to QT prolongation risk 1
Other Classes
Bupropion (Wellbutrin): 100-400 mg daily
Mirtazapine (Remeron): 15-45 mg daily
- Useful for patients with insomnia or appetite issues
- Sedating at lower doses (15 mg), less sedating at higher doses 1
Venlafaxine: 37.5-225 mg daily
- SNRI that may be more effective for severe depression
- Consider for patients who had partial response to Lexapro 1
Switching Strategy
When switching from Lexapro to another antidepressant, consider one of these approaches:
Direct switch: Discontinue Lexapro and start the new medication the next day
- Appropriate when switching between SSRIs
- Monitor for discontinuation symptoms
Cross-taper: Gradually reduce Lexapro while starting and increasing the new medication
- Preferred method when switching to a different class
- Reduces risk of discontinuation symptoms
Conservative approach: Complete washout of Lexapro before starting new medication
- Required when switching to/from MAOIs
- May be necessary with certain drug interactions 3
Special Considerations
Duration of Trial
- Allow adequate trial of the new medication (4-12 weeks) before determining efficacy
- In the STAR*D trial, only about 20% of patients remitted after switching from an initial SSRI
- Half of responses and two-thirds of remissions occurred after 6 weeks of treatment 4
- 33% of responses occurred after ≥9 weeks of treatment 4
Monitoring
- Assess for improvement in symptoms after 2 weeks - patients with at least 20% reduction in symptoms by week 2 are 6 times more likely to respond or remit 4
- Monitor for side effects specific to the new medication
Medication-Specific Considerations
When Switching to Bupropion
- Start with 37.5 mg every morning
- Increase by 37.5 mg every 3 days
- Target dose: 150 mg twice daily (second dose before 3 PM to minimize insomnia)
- Maximum daily dose: 300 mg to minimize seizure risk 2
- Contraindicated in patients with seizure disorders or agitation
- Requires 14-day washout if switching from MAOIs 2
When Switching to Another SSRI
- Can often be done with minimal washout due to similar mechanisms
- Consider the half-life of escitalopram (27-33 hours) when planning the switch 5
- Escitalopram is metabolized by CYP2C19, CYP2D6, and CYP3A4 - consider potential drug interactions with the new medication 5
Common Pitfalls to Avoid
- Inadequate trial duration: Many patients require 6-12 weeks for full response
- Improper dosing: Ensure therapeutic doses are reached
- Ignoring drug interactions: Check for potential interactions, especially when combining with other medications
- Overlooking discontinuation symptoms: Taper Lexapro gradually to minimize withdrawal effects
- Not considering the original reason for switching: If switching due to side effects, choose a medication with a different side effect profile
Remember that following an ineffective initial SSRI trial, more than half of patients may not achieve meaningful benefit with a second antidepressant, so setting realistic expectations is important 4.